SCHEMBL3467332

SCHEMBL3467332

Brc1cccc(/C=N/Nc2ncnc3[nH]cnc23)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.51
SMN1; SMN2 Q16637 6/20 0.51
NPC1 O15118 6/20 0.51
LMNA P02545 4/20 0.51
GAA P10253 5/20 0.48
KDM4E B2RXH2 4/20 0.48
L3MBTL1 Q9Y468 3/20 0.48
MAPT P10636 6/20 0.45
KMT2A Q03164 4/20 0.43
MEN1 O00255 2/20 0.43
POLB P06746 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
GSK3B P49841 2/20 0.42
EGFR P00533 2/20 0.41
HPGD P15428 2/20 0.41
MAPK1 P28482 1/20 0.41
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
GSK3A P49840 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3467339 1.00 RAB9A (0.51) RAB9ASMN1; SMN2NPC1LMNAGAA
SCHEMBL3467611 0.85 NPC1 (0.60) RAB9ASMN1; SMN2NPC1LMNAGAA
SCHEMBL3467469 0.85 RAB9A (0.51) RAB9ASMN1; SMN2NPC1LMNAGAA
SCHEMBL30677376 0.85 NPC1 (0.51) RAB9ASMN1; SMN2NPC1LMNAGAA
SCHEMBL3467476 0.85 RAB9A (0.51) RAB9ASMN1; SMN2NPC1LMNAGAA
SCHEMBL3467604 0.85 NPC1 (0.60) RAB9ASMN1; SMN2NPC1LMNAGAA
SCHEMBL3467761 0.84 RAB9A (0.56) RAB9ASMN1; SMN2NPC1LMNAGAA
SCHEMBL3467763 0.84 RAB9A (0.56) RAB9ASMN1; SMN2NPC1LMNAGAA
SCHEMBL3466886 0.82 RAB9A (0.51) RAB9ASMN1; SMN2NPC1LMNAGAA
SCHEMBL3467404 0.82 RAB9A (0.48) RAB9ASMN1; SMN2NPC1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010074746-A1 METHODS OF USE FOR OPSIN BINDING LIGANDS BIKAM PHARMACEUTICALS, INC. (US) 2010-07-01 WO disclosed
WO-2010074746-A1 METHODS OF USE FOR OPSIN BINDING LIGANDS BIKAM PHARMACEUTICALS, INC. (US) 2010-07-01 WO disclosed